英国制药巨头葛兰素史克(GSK.US)涨超7%，最高触及57.34美元，创下历史新高。消息面上，葛兰素史克去年总营收同比增长4%至326.7亿英镑，超过分析师预期的325亿英镑；归属于股东的净利润同比大幅增长121.7%至57.2亿英镑，合每股收益1.388英镑。期内，专科药物销售额同比增长17%，达到134.7亿英镑，主要得益于HIV药物需求强劲。董事会宣布派发季度股息每股0.18英镑，使得2025年全年股息达到每股0.66英镑，高于2024年的每股0.61英镑。(格隆汇)
英国制药巨头葛兰素史克(GSK.US)涨超7%，最高触及57.34美元，创下历史新高。消息面上，葛兰素史克去年总营收同比增长4%至326.7亿英镑，超过分析师预期的325亿英镑；归属于股东的净利润同比大幅增长121.7%至57.2亿英镑，合每股收益1.388英镑。期内，专科药物销售额同比增长17%，达到134.7亿英镑，主要得益于HIV药物需求强劲。董事会宣布派发季度股息每股0.18英镑，使得2025年全年股息达到每股0.66英镑，高于2024年的每股0.61英镑。(格隆汇)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.